Skip to content

CDR

Cephalon names Buchi as CEO

Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company’s board. The move comes following the death of Cephalon founder, chairman and CEO Frank Baldino Jr. earlier this month at age 57 from complications related to leukemia.

PhRMA elects new board members

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week announced the election of four new members to its board of directors. PhRMA said Tuesday that the new board members are Ian Read, president and chief executive officer of Pfizer Inc.; Jerzy Gruhn, president Novo Nordisk Inc.

NCPA, NACDS hail TRICARE pharmacy co-pay freeze

The National Community Pharmacists Association and the National Association of Chain Drug Stores have applauded lawmakers for approving a measure that freezes retail pharmacy co-payments in TRICARE, the health coverage program for the armed forces.

Analysts: Walgreens sharpens front-end execution

Analysts: Walgreens sharpens front-end execution

Financial analysts highlighted Walgreen Co.’s improved front-end performance in reports on the drug store chain’s fiscal 2011 first quarter results. "Walgreens appears to have established some positive momentum in its front-end business," William Blair & Co.

Olay professional facial cleansing system makes debut

Olay has introduced the Olay Professional Pro-X Advanced Cleansing System, which the Procter & Gamble Co. skin care brand said is first at-home facial cleansing tool that cleans and exfoliates as effectively as a professional cleansing system.